Edmond De Rothschild Investment Partners wraps up biotech and medical device fund at $430 mln
Edmond De Rothschild Investment Partners has closed its fifth European biotech and medical device venture fund at 345 million euros ($430 million). The fund beat its initial target of 250 million euros.
7 February 2018•2 mins read
